Sprinting into the 1.9 billion injection market, Sinopharm Group's application for doxofylline injection was accepted
Time of Update: 2022-04-20
Sales of terminal doxofylline injection in Chinese public medical institutions (unit: ten thousand yuan)Source: Minet.
com China's public medical institutions terminal competition patternUp to now, doxofylline injection has been reviewed by 14 companies, including Fuhe Pharmaceutical, Fuan Pharmaceutical, Yangzijiang, Shijiazhuang No.
More than half of gastrointestinal cancers in China are eaten
Time of Update: 2021-10-22
They analyzed the follow-up data of nearly 30,000 people from 1991 to 2011 and found that smoking, high red meat intake, obesity and other unhealthy life>.
Reduce brain atrophy by 65
Time of Update: 2021-08-05
On July 26, 2021, at the 2021 Alzheimer’s Association International Conference (AAIC-2021), Cognito Therapeutics, a company co-founded by Professor Lihui Cai from the Massachusetts Institute of Technology (MIT), demonstrated its treatment of Alzheimer’s disease ( AD) innovative sound and light therapy, positive results in a prospective phase 2 clinical trial for the treatment of patients with mild to moderate AD .
Express delivery only needs to be taken once a month, and the Phase 2 clinical results of long-acting HIV preventive therapy are positive
Time of Update: 2021-08-05
After 24 weeks, monthly oral islatravir showed good safety and tolerability, and 8 weeks after receiving the last dose of treatment, the level of islatravir in the subjects’ peripheral blood mononuclear cells (PBMCs) remained high To maintain the pharmacokinetic threshold of drug efficacy .
Will Pfizer return to the top 1 pharmaceutical company with its $26 billion sales blessing
Time of Update: 2021-05-21
S. dollars, while Pfizer predicts that the new crown vaccine’s annual sales will reach 26 billion U.
If it meets sales expectations, Moderna's new crown vaccine will also smoothly rank among the top 5 best-selling drugs in 2021.
Roche discontinues Phase III clinical study of antisense RNA therapy tominersen
Time of Update: 2021-05-03
Roche said that after the independent data committee "recommended the potential benefits and risk status of study participants based on investigating therapies," the company has stopped the administration of the third phase clinical study of the antisense drug tominersen for huntingtin and mutants.
Industry | "Post-epidemic" auto market: a rebound is imminent
Time of Update: 2021-03-28
In response to this situation, the central and local governments are intensively introducing various policies and measures to promote automobile consumption, such as relaxing purchase restrictions, promoting consumption of new energy vehicles, and promoting the development of smart vehicles.
All over the "ignition" Kangmei Pharmaceuticals half a year to throw more than 3 billion
Time of Update: 2021-02-27
On July 27th, Kangmei Pharmaceuticals, a leading Chinese medicine and beverage company, announced that, after consideration by the first interim shareholders' meeting in 2018, it had approved bills on
30% of U.S. hospital cardiac arrest cases are not treated in time
Time of Update: 2020-07-05
people generally think that if a cardiac cardiac arrest occurs in a hospital , it will be treated faster than elsewhere But a new US study suggests that this may be just a good wish Data show tha
A Brief History of the Third World of "The Internet and Great Health
Time of Update: 2020-06-05
Before moving on to this topic, learn a few related concepts: What is "Internet Plus"? What is "Big Health"? In fact, "Internet plus" is different from the concept of "Internet", the latter is such as
Patent for irinotecan hydrochloride injection and its preparation
Time of Update: 2020-04-03
Nanjing Chenggong Pharmaceutical Co., Ltd., a subsidiary of Nanjing hi tech holding company, has applied for the invention patent "a kind of irinotecan hydrochloride injection and its preparation meth
Trans stroke res: exosomes promote recovery after stroke
Time of Update: 2020-01-16
January 17, 2020 / bioun / -- in an article published in the journal translational stroke research this month, animal scientists funded by the National Institutes of health of the United States showed
The horizontal performance advantage of the pharmaceutical industry is prominent, or become the next round of investment focus
Time of Update: 2019-11-07
[pharmaceutical network market analysis] at present, the time point has entered the fourth quarter The industry believes that biomedicine, 5g industrial chain, non-bank finance and real estate are exp
With an annual growth of more than 1 billion yuan and potential of first-line epilepsy drugs, the first imitation will be launched soon
Time of Update: 2019-03-21
On March 21, Sihuan pharmaceutical announced that the application for the production approval of its epilepsy drug "escalicarpine acetate tablets" has been accepted by the State Food and Drug Administ
Li Junde: practice and case analysis of data reliability management in R & D laboratory
Time of Update: 2018-05-02
From June 29, 2018 to June 30, 2018, under the guidance of China Pharmaceutical University, Chongqing Municipal Economic and Information Commission, sponsored by pharma.com and China Pharmacy magazine